{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:40:07Z","timestamp":1749040807434,"version":"3.41.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771258"],"award-info":[{"award-number":["81771258"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.brainres.2025.149663","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T02:52:23Z","timestamp":1746067943000},"page":"149663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GBE1 alleviates MPTP-induced PD symptoms in mice by enhancing glycolysis and oxidative phosphorylation"],"prefix":"10.1016","volume":"1859","author":[{"given":"Hongyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongya","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.brainres.2025.149663_b0005","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1474-4422(24)00313-2","article-title":"Transcaucasian Parkinson's Disease C, Kaiyrzhanov R: A biobank for Parkinson's disease and atypical parkinsonism in central Asian and Transcaucasian regions","volume":"23","author":"Central","year":"2024","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.brainres.2025.149663_b0010","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cmet.2019.03.004","article-title":"Metabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice","volume":"29","author":"Polyzos","year":"2019","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.brainres.2025.149663_b0015","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S1474-4422(19)30404-1","article-title":"Glycolysis as a therapeutic target for Parkinson's disease","volume":"18","author":"Foltynie","year":"2019","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.brainres.2025.149663_b0020","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1113\/JP278810","article-title":"Revisiting the Warburg effect: historical dogma versus current understanding","volume":"599","author":"Vaupel","year":"2021","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.brainres.2025.149663_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112335","article-title":"Neurons require glucose uptake and glycolysis in vivo","volume":"42","author":"Li","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.brainres.2025.149663_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105605","article-title":"Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson's disease","volume":"163","author":"Li","year":"2022","journal-title":"Neurobiol Dis"},{"issue":"8","key":"10.1016\/j.brainres.2025.149663_b0035","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.cmet.2021.07.006","article-title":"Astrocyte-neuron metabolic cooperation shapes brain activity","volume":"33","author":"Bonvento","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.brainres.2025.149663_b0040","article-title":"Phosphoglycerate kinase is a central leverage point in Parkinson's disease-driven neuronal metabolic deficits","volume":"10(34):eadn6016","author":"Kokotos","year":"2024","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.brainres.2025.149663_b0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41531-023-00477-1","article-title":"Glycolysis-enhancing alpha(1)-adrenergic antagonists modify cognitive symptoms related to Parkinson's disease","volume":"9","author":"Weber","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.brainres.2025.149663_b0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12964-024-01478-0","article-title":"Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson's disease","volume":"22","author":"Chen","year":"2024","journal-title":"Cell Commun Signal"},{"issue":"10","key":"10.1016\/j.brainres.2025.149663_b0055","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1172\/JCI129987","article-title":"Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases","volume":"129","author":"Cai","year":"2019","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.brainres.2025.149663_b0075","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1186\/s12967-024-05852-x","article-title":"MST1, a novel therapeutic target for Alzheimer's disease, regulates mitochondrial homeostasis by mediating mitochondrial DNA transcription and the PI3K-Akt-ROS pathway","volume":"22","author":"Cui","year":"2024","journal-title":"J Transl Med"},{"issue":"9","key":"10.1016\/j.brainres.2025.149663_b0080","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.cmet.2024.05.016","article-title":"Astrocytic LRP1 enables mitochondria transfer to neurons and mitigates brain ischemic stroke by suppressing ARF1 lactylation","volume":"36","author":"Zhou","year":"2024","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.brainres.2025.149663_b0085","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/aps.2017.49","article-title":"Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease","volume":"38","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"10.1016\/j.brainres.2025.149663_b0090","first-page":"4544","article-title":"A Safe Feature Elimination Rule for L(1)-Regularized Logistic Regression","volume":"44","author":"Pan","year":"2022","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"issue":"6","key":"10.1016\/j.brainres.2025.149663_b0095","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1007\/s12035-023-03753-6","article-title":"A Diagnostic Model for Parkinson's Disease Based on Anoikis-Related Genes","volume":"61","author":"Bao","year":"2024","journal-title":"Mol Neurobiol"},{"issue":"5","key":"10.1016\/j.brainres.2025.149663_b0100","first-page":"2902","article-title":"Development and validation of a nomogram for pneumonia risk in burn patients with inhalation injury: a multicenter retrospective cohort study","volume":"110","author":"Li","year":"2024","journal-title":"Int J Surg"},{"issue":"2","key":"10.1016\/j.brainres.2025.149663_b0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/cid\/ciac775","article-title":"Development of a Human Immunodeficiency Virus Risk Prediction Model Using Electronic Health Record Data From an Academic Health System in the Southern United States","volume":"76","author":"Burns","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.brainres.2025.149663_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102452","article-title":"Friend or foe: Lactate in neurodegenerative diseases","volume":"101","author":"Wang","year":"2024","journal-title":"Ageing Res Rev"},{"issue":"4","key":"10.1016\/j.brainres.2025.149663_b0115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111338119","article-title":"Van Schaftingen E et al: Parkinson's disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite","volume":"119","author":"Heremans","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.brainres.2025.149663_b0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12974-022-02484-0","article-title":"A breakdown in microglial metabolic reprogramming causes internalization dysfunction of alpha-synuclein in a mouse model of Parkinson's disease","volume":"19","author":"Lu","year":"2022","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.brainres.2025.149663_b0125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-021-02187-y","article-title":"Early glycolytic reprogramming controls microglial inflammatory activation","volume":"18","author":"Cheng","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"28","key":"10.1016\/j.brainres.2025.149663_b0130","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4574","article-title":"Loss of UCHL1 rescues the defects related to Parkinson's disease by suppressing glycolysis","volume":"7","author":"Ham","year":"2021","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.brainres.2025.149663_b0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamaneurol.2020.5157","article-title":"Association of Glycolysis-Enhancing alpha-1 Blockers With Risk of Developing Parkinson Disease","volume":"78","author":"Simmering","year":"2021","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.brainres.2025.149663_b0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cmet.2014.04.017","article-title":"RGBErts LR et al: The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models","volume":"20","author":"Knight","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.brainres.2025.149663_b0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.brainres.2009.07.049","article-title":"Marked behavioral activation from inhibitory stimulation of locus coeruleus alpha1-adrenoceptors by a full agonist","volume":"1291","author":"Stone","year":"2009","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.brainres.2025.149663_b0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41392-020-0152-8","article-title":"Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"10.1016\/j.brainres.2025.149663_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051594","article-title":"GBE1 Promotes Glioma Progression by Enhancing Aerobic Glycolysis through Inhibition of FBP1","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers (basel)"},{"issue":"3","key":"10.1016\/j.brainres.2025.149663_b0160","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jimd.12325","article-title":"GBE1-related disorders: Adult polyglucosan body disease and its neuromuscular phenotypes","volume":"44","author":"Souza","year":"2021","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.brainres.2025.149663_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107525","article-title":"Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource","volume":"138","author":"Koch","year":"2023","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.brainres.2025.149663_b0170","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s13311-018-00684-2","article-title":"Myopathies Related to Glycogen Metabolism Disorders","volume":"15","author":"Tarnopolsky","year":"2018","journal-title":"Neurotherapeutics"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325002227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325002227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:58:15Z","timestamp":1749038295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899325002227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":31,"alternative-id":["S0006899325002227"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149663","relation":{},"ISSN":["0006-8993"],"issn-type":[{"type":"print","value":"0006-8993"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GBE1 alleviates MPTP-induced PD symptoms in mice by enhancing glycolysis and oxidative phosphorylation","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149663"}}